MMSI Merit Medical Systems, Inc., featured news, full reports, and detailed MMSI.O charts.
Merit Medical Systems, Inc. (MMSI) Wrap Up:
Merit Medical Systems, Inc. was formed in 1987 by several members of our current management to produce high-quality, single-use medical products. Our initial focus was on creating products to be used by doctors in diagnosing and treating cardiovascular disease. Our products are designed to enable physicians and other health care professionals to perform interventional and diagnostic procedures safely and effectively. Early in our development, we were able to introduce innovative new products and capture significant market share because of our expertise in product design, our proprietary technology, and our skills in injection and insert molding. Later, we developed an innovative line of angioplasty inflation products that included electronic sensing and display features. Angioplasty and stent placement are procedures used to clear out blockages and blood clots in arteries by inserting and inflating a small balloon in the clogged arteries. ... More..."http://secfilings.nasdaq.com/edgar_conv_html%2f2008%2f03%2f12%2f0001104659-08-017106.html#FIS_BUSINESS"
Merit Medical Systems Inc. (MMSI:NASDAQ)
Snapshot of Merit Medical Systems Inc. (MMSI)
|
OPEN
$17.00
|
PREVIOUS CLOSE
$17.20
|
|
|
DAY HIGH
$17.24
|
DAY LOW
$16.78
|
|
|
52 WEEK HIGH
07/29/09 - $19.54
|
52 WEEK LOW
03/9/09 - $9.57
|
|
|
MARKET CAP
480.3M
|
AVERAGE VOLUME 3 mo
234.1K
|
|
|
DILUTED EPS TTM
$0.80
|
SHARES OUTSTANDING
28.1M
|
|
|
MMSI Does Not Pay Dividends
|
P/E TTM
21.4x
|
|
| K = Thousands M = Millions B = Billions | ||
related news
MMSI Details
Merit Medical Systems, Inc. and its subsidiaries engage in the development, manufacture, and marketing of disposable medical devices that assist physicians in diagnosing disease and intervening in the areas of radiology and cardiology. The company offers inflation devices, hemostasis valves, vascular access products, angiography and angioplasty accessories, safety and waste management systems, obesity-related products, drainage catheters and accessories, paracentesis and pericardiocentesis catheters, therapeutic infusion catheters and accessories, products for dialysis and interventional nephrology, vein therapy, and discography products, as well as diagnostic catheters, guide wires, and torque devices. Merit Medical Systems also offers angiographic catheters, dialysis catheters, micro catheters and micro access products, guide wires, needles, safety products, therapeutic infusion catheters and accessories, drainage catheters and accessories, sheath introducers, pressure infusion bags, syringes, safety scalpels, kits, and procedure trays. In addition, it offers non-vascular interventional stents used for esophageal, tracheobronchial, and biliary stenting procedures. Further, Merit Medical Systems offers EN Snare, a body removal device that is used by physicians for retrieval and removal of stents, vena cava filters, and embolic coils, as well as the manipulation of AAA stent grafts and guidewire pull-throughs. The company serves hospital and clinic-based cardiologists, radiologists, anesthesiologists, physiatrists, pain management physicians, neurologists, nephrologists, vascular surgeons, technicians, and nurses. It serves customers through direct sales force, dealer organizations, distributors, OEM partners, and custom packagers and packers in the United States, Europe, Africa, the Middle East, Asia, South and Central America, and Canada. The company was founded in 1987 and is based in South Jordan, Utah.
MMSI Top Compensated Officers
Executives, Board Directors
Key developments for Merit Medical Systems Inc. (MMSI)
To present the company's history, products, financial performance and prospects
Merit Medical Systems Inc. reported unaudited earnings results for the third quarter and nine months ended September 30, 2009. The company reported revenues of $66.8 million for the quarter, an increase of 15% over revenues of $58.2 million for the third quarter of 2008. Net income for the quarter was $6.1 million, up 17% to $0.21 per share, compared to $5.2 million, or $0.18 per share, for the comparable quarter of 2008. Income from operations was $8.5 million for the third quarter of 2009, compared to $7.2 million for the third quarter of 2008. Income before income tax expense was $8.4 million against $7.4 million a year ago. Revenues for the nine-month period ended September 30, 2009 were a record $190.0 million, compared with $169.1 million for the comparable nine-month period in 2008, a gain of 12%. Net income was $17.5 million, up 14% to $0.61 per share, compared to $15.3 million, or $0.54 per share, for the same period of 2008. Income from operations was a record $25.3 million, compared to $22.8 million for the same period of 2008. Income before income tax expense was $25.5 million against $23.3 million a year ago.
Merit Medical Systems Inc., Q3 2009 Earnings Call, Oct 27 2009
MMSI Competitors
| Company | Last | Change |
| AngioDynamics Inc | $14.46 USD | -0.29 |
| Angiotech Pharmaceuticals Inc | C$1.49 CAD | 0.00 |
| Greatbatch Inc | $18.76 USD | -1.47 |
| ICU Medical Inc | $37.29 USD | +0.57 |
| Theragenics Corp | $1.41 USD | 0.00 |
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | MMSI | Industry Range |
| Price/Earnings | 21.4x |
|
| Price/Sales | 1.9x |
|
| Price/Book | 2.3x |
|
| Price/Cash Flow | 21.0x |
|
| TEV/Sales | 1.9x |
|
|
MMSI |
||
MMSI transactions
| Type Date |
Target |
|
Private Placement
October 21, 2009 |
Vysera Biomedical Ltd. |
|
Merger/Acquisition
June 2, 2009 |
Hatch Medical L.L.C., EN SnareĀ® Foreign Body Retrieval Device Assets |
More Recent News About Merit Medical Systems, Inc.
-
Merit Medical Systems to Announce Third Quarter Results on October 27, 2009
HASH(0x2a966b60c0) SOUTH JORDAN, Utah -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of...
Business Wire, 10/13/09 · More from publication
